Souhaitez-vous accéder aux communiqués récents ?

New York, July 29, 2026 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association (MDA) today announced that registration is now open for the 2027 MDA Clinical & Scientific Conference, taking place...

~ U.S. and U.K. regulatory submissions for AMT-130 for Huntington’s disease on track as planned for the third quarter of 2026 ~ ~ Topline four-year data from the Phase I/II study of AMT-130 expected...

SEATTLE, July 29, 2026 (GLOBE NEWSWIRE) -- Shape Therapeutics, a leader in RNA editing-based gene therapy, today announced that it has been awarded a research grant from The Michael J. Fox...

Dublin, July 21, 2026 (GLOBE NEWSWIRE) -- The "Gene Therapy Collaboration and Licensing Deals 2016-2026" has been added to ResearchAndMarkets.com's offering.This report provides a comprehensive and...

SK pharmteco announced details of its partnership with Genethon, a France-based nonprofit R&D organization dedicated to gene therapy for genetic diseases.

Allogenetics today announced the appointment of Jeroen Rovers, MD, PhD, as Chief Medical Officer.

Dublin, July 20, 2026 (GLOBE NEWSWIRE) -- The "Cell and Gene Therapy Global Market Opportunities and Strategies to 2035" has been added to ResearchAndMarkets.com's offering. The global cell...

Applied Biologics announces manufacture of its first research construct for the preclinical DMOAD Gene Therapy Program.

Pluristyx secures a Series A priced round initial close led by a multinational Fortune 500 company to accelerate growth and expand its stem cell platform.

Siren Biotechnology awarded $8M in grant funding from the California Institute for Regenerative Medicine (CIRM) to support clinical development of SRN-101